Nanoform is exhibiting at CPHI Milan 2026 to explore nanoparticle-engineering technologies supporting high-concentration biologics, IV to SC administration, reduced injection volumes, patient convenience and adherence, bioavailability for challenging molecules, and new formulation and lifecycle management opportunities for complex small molecules.

Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services. Nanoform’s capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications.

Founded 2015